News
Stay informed with Dissolution Tester News, featuring the latest advancements, industry trends, and updates in pharmaceutical testing technology. Discover new features, regulatory changes, and innovative solutions for accurate drug release analysis, ensuring quality and compliance in drug development and manufacturing.
Filter by Popular Tags
Online UV Dissolution Testing System: Real-Time Data for Faster Drug Release Decisions
Online UV dissolution testing systems provide the pharmaceutical industry's first means to gain highly valuable, insight-rich process data, and do so without interrupting a dissolution run. Results of traditional offline ...
High Precision Dissolution Tester With ≤±0.3 Rpm Steady Error – No Compromise On Repeatability
For pharmaceutical quality control labs, reliable dissolution testing is grounded in repeatability. When dosage forms do not behave consistently, a root cause analysis generally does not focus on the product ...
Drug Dissolution Apparatus Supplier: Smart Automation Tech, Halves Sampling Errors
As an innovative retailer of Drug Dissolution Apparatus, RAYTOR understands that the foundation of accurate pharmaceutical testing is reliable sampling. The new RT600 Dissolution Apparatus shows how the smart automation technology ...
Tablet Dissolution Testing Equipment India: Designed for 2026's Flexible Formulation Pipeline
Tablet Dissolution Testing Equipment India has come a long way from the foundational stages of quality control. As pharmaceutical pipelines diversify into complex oral solids, patches, parenterals, and semi-solids, labs ...
Transdermal Diffusion Testing Equipment: Why 2026 Demands Smarter Automation
Transdermal Diffusion Testing Equipment has been crucial for IVRT and IVPT studies. However, manual workflows posed a compliance risk for 2026 and beyond. The global automated diffusion cell market, driven ...
Double Your Data: The Dual-Group Franz Diffusion Cell Apparatus for Patches
The transdermal patches market is booming—$8.02 billion in 2026, rising to $13.27 billion by 2034. As labs rush to develop new patches, the Franz diffusion cell apparatus for patches remains ...